Philip Bejon/PLoS One

MALDI-TOF MS for malaria vector surveillance: A cost-comparison analysis using a decision-tree approach.Karisa J Rist C Tuwei M Ominde K Bartilol B Ondieki Z Musani H Wanjiku C Mwangangi J Mbogo C Rono M Bejon P Maia M
PLoS One, (2025). 20:e0335764

Induction of an early IFN-gamma cellular response and high plasma levels of SDF-1alpha are inversely associated with COVID-19 severity and residence in rural areas in Kenyan patients.Wanjiku P Orindi B Kimotho J Sayed S Shah R Saleh M Mwacharo J Maronga C Olouch V Karanu A Shah J Nneka Z Ochola-Oyier LI Abdi AI Dunachie S Bejon P Nduati EW Ndungu FM
PLoS One, (2025). 20:e0316967

Making MALDI-TOF MS for entomological parameters accessible: A practical guide for in-house library creation.Karisa J Tuwei M Ominde K Bartilol B Ondieki Z Musani H Rono M Mbogo C Bejon P Mwangangi J Wanjiku C Maia M
PLoS One, (2025). 20:e0330605

Correlations between three ELISA protocols measurements of RTS,S/AS01-induced anti-CSP IgG antibodies.Mugo RM Orindi B Shee FM Bellamy D Mwacharo J Ewer KJ Bejon P Ndungu FM
PLoS One, (2023). 18:e0286117

Validation of saline, PBS and a locally produced VTM at varying storage conditions to detect the SARS-CoV-2 virus by qRT-PCR.Ngetsa C Osoti V Okanda D Marura F Shah K Karanja H Mugo D Gitonga J Mutunga M Lewa C Orindi B Bejon P Ochola-Oyier LI
PLoS One, (2023). 18:e0280685

Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020-21.Lucinde RK Mugo D Bottomley C Karani A Gardiner E Aziza R Gitonga JN Karanja H Nyagwange J Tuju J Wanjiku P Nzomo E Kamuri E Thuranira K Agunda S Nyutu G Etyang AO Adetifa IMO Kagucia E Uyoga S Otiende M Otieno E Ndwiga L Agoti CN Aman RA Mwangangi M Amoth P Kasera K Nyaguara A Ng'ang'a W Ochola LB Namdala E Gaunya O Okuku R Barasa E Bejon P Tsofa B Ochola-Oyier LI Warimwe GM Agweyu A Scott JAG Gallagher KE
PLoS One, (2022). 17:e0265478

Determinants of improvement trends in health workers' compliance with outpatient malaria case-management guidelines at health facilities with available "test and treat" commodities in Kenya.Amboko B Stepniewska K Malla L Machini B Bejon P Snow RW Zurovac D
PLoS One, (2021). 16:e0259020

The relationship between facility-based malaria test positivity rate and community-based parasite prevalence.Kamau A Mtanje G Mataza C Malla L Bejon P Snow RW
PLoS One, (2020). 15:e0240058

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.Tiono AB Nebie I Anagnostou N Coulibaly AS Bowyer G Lam E Bougouma EC Ouedraogo A Yaro JBB Barry A Roberts R Rampling T Bliss C Hodgson S Lawrie A Ouedraogo A Imoukhuede EB Ewer KJ Viebig NK Diarra A Leroy O Bejon P Hill AVS Sirima SB
PLoS One, (2018). 13:e0208328

Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.Mensah VA Gueye A Ndiaye M Edwards NJ Wright D Anagnostou NA Syll M Ndaw A Abiola A Bliss C Gomis JF Petersen I Ogwang C Dieye T Viebig NK Lawrie AM Roberts R Nicosia A Faye B Gaye O Leroy O Imoukhuede EB Ewer KJ Bejon P Hill AV Cisse B Mvvc group
PLoS One, (2016). 11:e0167951

Changing Malaria Prevalence on the Kenyan Coast since 1974: Climate, Drugs and Vector Control.Snow RW Kibuchi E Karuri SW Sang G Gitonga CW Mwandawiro C Bejon P Noor AM
PLoS One, (2015). 10:e0128792

Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children.Olotu A Clement F Jongert E Vekemans J Njuguna P Ndungu FM Marsh K Leroux-Roels G Bejon P
PLoS One, (2014). 9:e115126

Plasmodium falciparum malaria in children aged 0-2 years: the role of foetal haemoglobin and maternal antibodies to two asexual malaria vaccine candidates (MSP3 and GLURP).Kangoye DT Nebie I Yaro JB Debe S Traore S Ouedraogo O Sanou G Soulama I Diarra A Tiono A Marsh K Sirima SB Bejon P
PLoS One, (2014). 9:e107965

A genome wide association study of Plasmodium falciparum susceptibility to 22 antimalarial drugs in Kenya.Wendler JP Okombo J Amato R Miotto O Kiara SM Mwai L Pole L O'Brien J Manske M Alcock D Drury E Sanders M Oyola SO Malangone C Jyothi D Miles A Rockett KA MacInnis BL Marsh K Bejon P Nzila A Kwiatkowski DP
PLoS One, (2014). 9:e96486

The relationship between RTS,S vaccine-induced antibodies, CD4(+) T cell responses and protection against Plasmodium falciparum infection.White MT Bejon P Olotu A Griffin JT Riley EM Kester KE Ockenhouse CF Ghani AC
PLoS One, (2013). 8:e61395

Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.Ogwang C Afolabi M Kimani D Jagne YJ Sheehy SH Bliss CM Duncan CJ Collins KA Garcia Knight MA Kimani E Anagnostou NA Berrie E Moyle S Gilbert SC Spencer AJ Soipei P Mueller J Okebe J Colloca S Cortese R Viebig NK Roberts R Gantlett K Lawrie AM Nicosia A Imoukhuede EB Bejon P Urban BC Flanagan KL Ewer KJ Chilengi R Hill AV Bojang K
PLoS One, (2013). 8:e57726

The ratio of monocytes to lymphocytes in peripheral blood correlates with increased susceptibility to clinical malaria in Kenyan children.Warimwe GM Murungi LM Kamuyu G Nyangweso GM Wambua J Naranbhai V Fletcher HA Hill AV Bejon P Osier FH Marsh K
PLoS One, (2013). 8:e57320

Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in Kenya.Ibison F Olotu A Muema DM Mwacharo J Ohuma E Kimani D Marsh K Bejon P Ndungu FM
PLoS One, (2012). 7:e52939

A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E.Ndungu FM Mwacharo J Kimani D Kai O Moris P Jongert E Vekemans J Olotu A Bejon P
PLoS One, (2012). 7:e52870

Estimating individual exposure to malaria using local prevalence of malaria infection in the field.Olotu A Fegan G Wambua J Nyangweso G Ogada E Drakeley C Marsh K Bejon P
PLoS One, (2012). 7:e32929